DMC Recommends ArQule (ARQL), Daiichi Sankyo Discontinue Phase 3 MARQUEE Trial

Go back to DMC Recommends ArQule (ARQL), Daiichi Sankyo Discontinue Phase 3 MARQUEE Trial